BD Announces Results for Fourth Fiscal Quarter and... (rcent over theprior year period and refl...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

BD Announces Results for Fourth Fiscal Quarter and Full Year

Date:11/1/2007

rcent over the prior year period, and reflected an estimated 5 percent favorable impact from foreign currency translation.

For the full fiscal year ended September 30, 2007, revenues in the U.S. were $3.033 billion, representing an increase of 11 percent over the prior year period. Revenues outside of the U.S. were $3.327 billion, representing an increase of 11 percent over the prior year period, and reflected an estimated 5 percent favorable impact from foreign currency translation.

Fiscal 2008 Outlook for Full Year

The Company estimates that diluted earnings per share from continuing operations for the full fiscal year 2008 will increase approximately 10 to 12 percent over diluted earnings per share from continuing operations, excluding specified items, of $3.84 for the fiscal year 2007.

Conference Call Information

A conference call regarding BD's fourth fiscal quarter and full year results and its expectations for fiscal year 2008 will be broadcast live on BD's website, http://www.bd.com/investors, at 10:00 a.m. (ET) Thursday, November 1, 2007. The conference call will be available for replay through the close of business on November 8, 2007 on BD's website, http://www.bd.com/investors, or at 1- 800-475-6701 (domestic) and 1-320-365-3844 (international), access code 889224.

This news release contains certain non-GAAP financial measures. A reconciliation of these and other measures to the comparable GAAP measures is included in this release and in the attached financial tables.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and d
'/>"/>

SOURCE BD (Becton Dickinson and Company)
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:

(Date:5/24/2013)... May 23 (HealthDay News) -- Certain statins -- ... your chances of developing type 2 diabetes, a ... for patients taking atorvastatin (brand name Lipitor), rosuvastatin ... Focusing on almost 500,000 Ontario residents, researchers ... developing diabetes were low in patients prescribed statins. ...

(Date:5/24/2013)... National Geographic questioned in an article on ... remembrance is getting lost in the swirl of summer kickoff. ... prompted some research and analysis on the subject based on ... statistical evaluation of around 180 ecards shared by Americans, suggests ... emotions of fun and celebration. In the modern era ...

(Date:5/24/2013)... Dallas, Texas (PRWEB) May 24, 2013 ... to 2022” provides an overview of the risk factors ... markets (8MM) (US, France, Germany, Italy, Spain, UK, Australia, ... incident cases of meningococcal disease segmented by age (<1, ... serogroup (B, C, Y, and W-135) in these markets. ...

(Date:5/24/2013)... 2013 Just about any bodyweight training program ... a trainer based in Dallas, GA that uses a variety ... pushup that is not used enough. , “The medicine ... standard pushup more challenging. By keeping your hands on a ... abs are being worked much harder than a standard pushup. ...

(Date:5/24/2013)... (PRWEB) May 24, 2013 Patients who ... more likely to suffer from gastroesophageal reflux disease or ... reported in a study published today. , The article, ... Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal Impedance” ... could be of great importance to individuals who live ...

Breaking Medicine News(10 mins):Health News:Could Statins Raise Diabetes Risk? 2 Health News:Could Statins Raise Diabetes Risk? 3 Health News:Is Memorial Day More Than A Three-Day Weekend 2 Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2 Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3 Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4 Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2 Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2

[0] Could Statins Raise Diabetes Risk?[0] Is Memorial Day More Than A Three-Day Weekend [0] Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com [0] Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com [0] West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough

... million, up 7.6% from the first ... quarter of 2007., - Same ... March 31, 2008 over the corresponding period ended in 2007.,- Cash From Facility ... 19% increase over the first period of 2007, and was $0.41 per ...

... drugs that work by blocking brain molecules similar to ... in young children, according to a new study from ... is known to be an appetite stimulant, and a ... Acomplia) developed by Sanofi-Aventis and awaiting approval for use ...

... The American Academy,of Physician Assistants (AAPA), representing ... U.S., is pleased to join other national,organizations ... Treating Tobacco Use and Dependence: 2008 Update., ... even stronger,evidence to support the efforts of ...

... SAO PAULO, Brazil, May 7 Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the following webcast:, ... When: Thursday, May 8, 2008 @ 12:00 PM EDT, Where: ... Internet -- Simply log on to the web at the ... Conference call dial-in phone numbers: ...

... a Puzzling Pediatric Tumor--, PHILADELPHIA, May 7 ... for the,first time identified a chromosome region that is ... an often fatal childhood cancer., The investigators found ... of chromosome 6 raises the risk that a child ...

... French . , Ottawa (May 7, 2008) ... today funding from the Canadian Institutes of Health Research ... over $298 million. Minister Clement was joined by Dr. ... Po-Yin Cheung, a neonatologist and CIHR-funded researcher from the ...

Brookdale Announces First Quarter 2008 Results MIT study suggests caution on new anti-obesity drug in kids AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence Webcast Alert: Medial Saude S/A Announces First Quarter 2008 Earnings Conference Call Webcast Researchers Find Gene Location That Gives Rise to Neuroblastoma, an Aggressive Childhood Cancer CIHR news: health research touching lives

(Date:5/23/2013)... 2013 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... 2013 Life Science Firm of the Year by the Tech ... honored at the TCM,s 25 th Annual Tech Awards ... Tech Awards Celebration recognizes the leaders and innovators in the ... and the surrounding regions. "We are ...

(Date:5/23/2013)... 23, 2013 Amgen (NASDAQ: AMGN ) ... Healthcare Conference on Thursday, May 30, 2013, at the Westin ... 9:20 a.m. Eastern Daylight Time. Arvind Sood ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...

(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...

Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4

[0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland [0] Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference [0] Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises

... & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun,4, 2007 - ... the presentation of data from its Quinamed(R),(amonafide ... a genotypically optimised dose of Quinamed in,heavily ... tumors. The,key outcomes from this study were ...

... in Journal Heart Finds Taxus Stent,Implantation of Multiple Stents ... for Another Procedure, , MIAMI LAKES, Fla., ... analysis of data from the Western Denmark Heart,Registry found ... open a clogged artery were less,likely to need another ...

Cached Medicine Technology:ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 2 ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 3 ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 4 New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings 2 New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings 3

ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

T-Cell Immunodeficiency Extended Profile T-Cell Clonality Assessment by Restriction Fragment Southern Blot Hybridization, Fluid Syphilis Antibody, IgM by ELISA Susceptibility